Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Zaja

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Oncotargets and Therapy|June 14, 2014
Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomasStefano Volpetti, Francesco Zaja, Renato Fanin
Haematologica|May 26, 2019
Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?Elisa Lucchini, Francesco Zaja, James Bussel
European Journal of Internal Medicine|October 3, 2018
Management of immune thrombocytopenia in elderly patientsElisa Lucchini, Renato Fanin, Nichola Cooper, et al.
Leukemia & Lymphoma|July 20, 2013
Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategiesFrancesco Zaja, Massimo Federico, Umberto Vitolo, et al.
Expert Review of Hematology|November 1, 2021
Immune thrombocytopeniaJames Bussel, Nichola Cooper, Ralph Boccia, et al.
Platelets|February 21, 2023
European Delphi panel to build consensus on tapering and discontinuing thrombopoietin receptor agonists in immune thrombocytopeniaAdele Barlassina, Tomás José González-López, Nichola Cooper, et al.
Leukemia & Lymphoma|January 17, 2018
Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countriesGraham P Collins, Antonio Rueda, Gilles Salles, et al.
Haematologica|July 2, 2002
Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myelomaFrancesca Patriarca, Alessandra Sperotto, Carla Filì, et al.
Clinical & Developmental Immunology|September 8, 2012
Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapyLuca Arcaini, Michele Merli, Stefano Volpetti, et al.
American Journal of Hematology|December 23, 2011
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximabFrancesco Zaja, Luciana Marin, Marianna Chiozzotto, et al.
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Oncotargets and Therapy|June 14, 2014
Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomasStefano Volpetti, Francesco Zaja, Renato Fanin
Haematologica|May 26, 2019
Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?Elisa Lucchini, Francesco Zaja, James Bussel
European Journal of Internal Medicine|October 3, 2018
Management of immune thrombocytopenia in elderly patientsElisa Lucchini, Renato Fanin, Nichola Cooper, et al.
Leukemia & Lymphoma|July 20, 2013
Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategiesFrancesco Zaja, Massimo Federico, Umberto Vitolo, et al.
Expert Review of Hematology|November 1, 2021
Immune thrombocytopeniaJames Bussel, Nichola Cooper, Ralph Boccia, et al.
Platelets|February 21, 2023
European Delphi panel to build consensus on tapering and discontinuing thrombopoietin receptor agonists in immune thrombocytopeniaAdele Barlassina, Tomás José González-López, Nichola Cooper, et al.
Leukemia & Lymphoma|January 17, 2018
Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countriesGraham P Collins, Antonio Rueda, Gilles Salles, et al.
Haematologica|July 2, 2002
Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myelomaFrancesca Patriarca, Alessandra Sperotto, Carla Filì, et al.
Clinical & Developmental Immunology|September 8, 2012
Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapyLuca Arcaini, Michele Merli, Stefano Volpetti, et al.
American Journal of Hematology|December 23, 2011
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximabFrancesco Zaja, Luciana Marin, Marianna Chiozzotto, et al.
Pageof 15